Aberrant RNA Processing in a Neurodegenerative Disease: the Cause for Absent EAAT2, a Glutamate Transporter, in Amyotrophic Lateral Sclerosis
Open Access
- 1 March 1998
- Vol. 20 (3) , 589-602
- https://doi.org/10.1016/s0896-6273(00)80997-6
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Mutations in the glutamate transporter EAAT2 gene do not cause abnormal EAAT2 transcripts in amyotrophic lateral sclerosisAnnals of Neurology, 1998
- Increased 3‐nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosisAnnals of Neurology, 1997
- Glutamate transporter gene expression in amyotrophic lateral sclerosis motor cortexAnnals of Neurology, 1996
- Superoxide dismutase and familial amyotrophic lateral sclerosis: New insights into mechanisms and treatmentsAnnals of Neurology, 1996
- Superoxide Dismutase Concentration and Activity in Familial Amyotrophic Lateral SclerosisJournal of Neurochemistry, 1995
- Functional comparisons of three glutamate transporter subtypes cloned from human motor cortexJournal of Neuroscience, 1994
- El escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosisJournal of the Neurological Sciences, 1994
- Evidence for autoimmunity in amyotrophic lateral sclerosisJournal of the Neurological Sciences, 1994
- A Controlled Trial of Riluzole in Amyotrophic Lateral SclerosisNew England Journal of Medicine, 1994
- Superoxide Dismutase Activity, Oxidative Damage, and Mitochondrial Energy Metabolism in Familial and Sporadic Amyotrophic Lateral SclerosisJournal of Neurochemistry, 1993